A study using selective ACKR3 modulators emphasized the involvement of ACKR3 in GSC growth in vitro together with CXCR4, although this report revealed that GSC tumor formation in vivo was independent of CXCR4 or ACKR3 activity [80]. The gene discussed is ACKR3; the disease is neoplasm.